Chronic Disease
Our work in Chronic Disease
-
Improving Care of People with Serious Medical Illness: An Economic Research Agenda for Palliative Care
In 2020, Schaeffer Center established an Advisory Panel on Palliative Care. In this post, the panel outlines next steps to increase the quality of care of frail people with multiple chronic conditions.
Categorized in Evidence Base -
Middlemen, Not Drug Companies, Are Pushing Up Insulin Prices, and Congress Doesn’t Have the Right Plan to Fight Back
Congress should take advantage of the current political climate and start reining in the intermediaries in the drug distribution system.
-
Patient and Physician Perspectives On Engaging in Palliative and Healthcare Trials: A Qualitative Descriptive Study
Researchers are encountering increasing challenges in recruiting participants for palliative and healthcare research. This paper aims to understand challenges to and methods for engaging physicians and seriously ill patients and their caregivers in research studies.
-
Early Transplantation Maximizes Survival in Severe Acute-On-Chronic Liver Failure: Results of a Markov Decision Process Model
The researchers create a Markov decision process model to maximize overall survival among patients listed for liver transplantation with grade three acute-on-chronic liver failure (ACLF-3) within the first 7 days of listing
-
After Their Initial Diagnosis, Many Adult COVID-19 Patients Continue Seeking Medical Care for up to Six Months or More
Analyzing claims data, does COVID-19 related healthcare utilization persist in for 180 days or more, also known as long COVID, after their initial diagnosis?
-
Challenging Assumptions of Outcomes and Costs Comparing Peritoneal and Hemodialysis
Policy makers have suggested increasing peritoneal dialysis (PD) would improve end-stage kidney disease (ESKD) outcomes and reduce Medicare spending compared with hemodialysis (HD). We compared mortality, hospitalizations, and Medicare spending between PD and HD among uninsured adults with incident ESKD.
Categorized in Research -
Multi-Cancer Blood Tests Can Reduce Late-Stage Cancer Diagnosis in Black and Latino Patients
A new white paper published by the USC Schaeffer Center focuses on the potential benefit of multi-cancer early detection (MCED) blood-based tests to reduce disparities in late-stage cancer diagnosis among minority populations.
-
Latinos Are More Likely to Die From COVID-19, Underlining Racial and Ethnic Disparities in Outcomes
Latinos were tested more for COVID-19 and had higher rates of infection, hospitalization and death.
-
Reducing Racial Disparities in Early Cancer Diagnosis With Blood-Based Tests
A new white paper published by the USC Schaeffer Center focuses on multi-cancer, early detection, (MCED) blood-based tests as one solution to reduce disparities in late-stage cancer diagnosis among minority populations.
-
Measuring Real-World Effectiveness and Value
Precision therapies are often approved based on small trials, in specialized settings, and using biomarkers as endpoints. Thus, despite their potential high cost, the evidence of value is lacking which makes real-world evidence crucial.